METAGENOMI THERAPEUTICS INC (MGX) Earnings History & Surprises

NASDAQ:MGX • US59102M1045

Current stock price

1.44 USD
-0.02 (-1.37%)
At close:
1.42 USD
-0.02 (-1.39%)
After Hours:

MGX Earnings overview

Past quarterly earnings results for METAGENOMI THERAPEUTICS INC (MGX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 8, 2026
Period
Q1 / 2026
EPS Estimate
-$0.53
Revenue Estimate
6.632M

Last Reported

Most Recent
Release Date
Mar 5, 2026
Period
Q4 / 2025
EPS Reported
-$0.60
EPS Surprise
1.87%
Revenue Surprise
-42.59%

Beat Rate

Last 8 Quarters
75%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -0.60 -0.61 1.87% 4.76% 3.911M 6.812M -42.59% -59.32%
Q3 2025 -0.55 -0.59 6.75% -7.84% 8.659M 7.474M 15.85% -24.80%
Q2 2025 -0.54 -0.63 13.90% -86.21% 8.513M 7.797M 9.18% -57.45%
Q1 2025 -0.68 -0.58 -16.48% 42.86% 4.127M 8.04M -48.67% -63.02%
Q4 2024 -0.63 -0.76 16.83% -22.57% 9.614M 8.804M 9.20% -22.46%
Q3 2024 -0.51 -0.78 34.90% - 11.514M 6.854M 67.99% -6.87%
Q2 2024 -0.29 -0.66 56.01% - 20.008M 14.12M 41.70% 0.07%
Q1 2024 -1.19 -0.78 -51.70% - 11.159M 7.996M 39.56% -
Q4 2023 -0.51 -2.06 75.08% - 12.399M 9.595M 29.22% -27.91%
Q3 2023 - - 12.363M - -
Q2 2023 - - 19.994M - -
Q4 2022 - - 17.2M - 6,978.19%
Q4 2021 - - 243K - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

MGX EPS Q2Q GrowthMGX EPS Q2Q GrowthEPS Q2Q Growth Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26 Q2/26 Q3/26 Q4/26 0 20 -20 40 -40 -60 -80

Revenue Historical Q2Q growth and Acceleration

MGX Revenue Q2Q GrowthMGX Revenue Q2Q GrowthRevenue Q2Q Growth Q4/22 Q4/23 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26 Q2/26 Q3/26 Q4/26 0 2K 4K 6K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
3
Average EPS beat (4)
1.51%
Max EPS beat (4)
13.90%
Min EPS beat (4)
-16.48%

Revenue beat statistics

Revenue beat (4)
2
Average Revenue beat (4)
-16.55%
Max Revenue beat (4)
15.86%
Min Revenue beat (4)
-48.67%

Analysis

In the last 4 quarters, MGX has beaten EPS estimates in 3 out of 4 releases
MGX has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, MGX has beaten the EPS estimates by 1.5% on average.
In the last 4 quarters, MGX reported -16.6% below the revenue estimates on average.
MGX Overview MGX Technical Analysis Report MGX Fundamental Analysis Report MGX Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

METAGENOMI THERAPEUTICS INC / MGX Earnings FAQ

Can you provide the last earnings date for METAGENOMI THERAPEUTICS INC?

METAGENOMI THERAPEUTICS INC (MGX) last reported earnings on 3/5/2026.

Did METAGENOMI THERAPEUTICS INC (MGX) beat earnings estimates last quarter?

METAGENOMI THERAPEUTICS INC (MGX) beat EPS estimates and missed revenue estimates in the most recent quarter.

What percentage of the time does MGX stock beat earnings estimates?

In the last 4 quarters, METAGENOMI THERAPEUTICS INC (MGX) has beaten EPS estimates in 3 out of 4 releases.